Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Operating Expenses | 4,160 | 4,382 | 2,844 | 3,650 | 3,287 |
| Operating Income | -4,160 | -4,382 | -2,844 | -3,650 | -3,287 |
| Other Income | 3,517 | -2,286 | -13,753 | -903 | 909 |
| Pre-tax Income | -643 | -6,667 | -16,598 | -4,553 | -2,377 |
| Net Income Continuous | -643 | -6,667 | -16,598 | -4,553 | -2,377 |
| Net Income | $-643 | $-6,667 | $-16,598 | $-4,553 | $-2,377 |
| EPS Basic Total Ops | 0.00 | -0.04 | -0.13 | -0.03 | -0.02 |
| EPS Basic Continuous Ops | 0.00 | -0.04 | -0.12 | -0.03 | -0.02 |
| EPS Diluted Total Ops | 0.00 | -0.04 | -0.13 | -0.03 | -0.02 |
| EPS Diluted Continuous Ops | 0.00 | -0.04 | -0.12 | -0.03 | -0.02 |
| EBITDA(a) | $-3,990 | $-4,212 | $-2,675 | $-3,481 | $-3,118 |